Ontology highlight
ABSTRACT: Background
Patient-level data are available for 11 randomized, controlled, Phase III/Phase IV solifenacin clinical trials.Methods
Meta-analyses were conducted to interrogate the data, to broaden knowledge about solifenacin and overactive bladder (OAB) in general. Before integrating data, datasets from individual studies were mapped to a single format using methodology developed by the Clinical Data Interchange Standards Consortium (CDISC). Initially, the data structure was harmonized, to ensure identical categorization, using the CDISC Study Data Tabulation Model (SDTM). To allow for patient level meta-analysis, data were integrated and mapped to analysis datasets. Mapping included adding derived and categorical variables and followed standards described as the Analysis Dat
SUBMITTER: Chapple CR
PROVIDER: S-EPMC5935888 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature